Psychiatric Comorbidity and Other Psychological Factors in Patients with "Chronic Lyme Disease"

American Journal of Medicine

Volumn 122, Issue 9, 2009, Pages 843-850

  Hassett, Afton L ^a   Radvanski, Diane C ^a   Buyske, Steven ^b   Savage, Shantal V ^a   Sigal, Leonard H ^a,c  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Anxiety; Chronic Lyme disease; Chronic Multisymptom Illness; Depression; Fibromyalgia; Lyme disease; Psychiatric comorbidity

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CHRONIC DISEASE; COMORBIDITY; DEPRESSION; FEMALE; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; PERSONALITY DISORDER; PRIORITY JOURNAL; SCREENING; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BORRELIA BURGDORFERI; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; HUMANS; LYME DISEASE; MENTAL DISORDERS; MIDDLE AGED; YOUNG ADULT;

EID: 68749115173     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.02.022     Document Type: Article

References (49)

1. Steere A.C. Lyme disease. N Engl J Med 345 (2001) 115-124
2. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43 (2006) 1089-1134
3. Asch E.S., Bujak D.I., Weiss M., et al. Lyme disease: an infectious and postinfectious syndrome. J Rheumatol 21 (1994) 454-461
4. Bujak D.I., Weinstein A., and Dornbush R.L. Clinical and neurocognitive features of the post Lyme syndrome. J Rheumatol 23 (1996) 1392-1397
5. Seltzer E.G., Gerber M.A., Cartter M.L., et al. Long-term outcomes of persons with Lyme disease. JAMA 283 5 (2000) 609-616
6. Shadick N.A., Phillips C.B., Logigian E.L., et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med 121 8 (1994) 560-567
7. Shadick N.A., Phillips C.B., Sangha O., et al. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann Intern Med 131 (1999) 919-926
8. Smith R.P., Schoen R.T., Rahn D.W., et al. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med 136 (2002) 421-428
9. Yrjänäinen H., Hytönen J., Song X.Y., et al. Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice. J Infect Dis 195 (2007) 1489-1496
10. Klempner M.S. Controlled trials of antibiotic treatment in patients with post-treatment chronic Lyme disease. Vector Borne Zoonotic Dis 2 (2002) 255-263
11. Marques A.R., Stock F., and Gill V. Evaluation of a new culture medium for Borrelia burgdorferi. J Vet Diagnos Invest 3 (2000) 350-352
12. Feder H.M., Johnson B.J., O'Connell S., et al. A critical appraisal of "chronic Lyme disease". N Engl J Med 357 (2007) 1422-1430
13. Cameron D., Gaito A., Harris N., et al., ILADS Working Group. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther 2 1 Suppl (2004) S1-S13
14. Sigal L.H. Summary of the first 100 patients seen at a Lyme disease referral center. Am J Med 88 (1990) 577-581
15. Sigal L.H. The Lyme disease controversy. Social and financial costs of misdiagnosis and mismanagement. Arch Intern Med 156 (1996) 1493-1500
16. Sigal L.H., and Hassett A.L. Commentary: 'What's in a name? That which we call a rose by any other name would smell as sweet.'. Shakespeare W. Romeo and Juliet, II, ii(47-48). Int J Epidemiol 34 (2005) 1345-1347
17. Klempner M.S., Hu L.T., Evans J., et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345 (2001) 85-92
18. Hsu V.M., Patella S.J., and Sigal L.H. Chronic Lyme disease as the incorrect diagnosis in patients with fibromyalgia. Arthritis Rheum 36 (1993) 1493-1500
19. Reid M.C., Schoen R.T., Evans J., et al. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med 128 (1998) 354-362
20. Steere A.C., Taylor E., McHugh G.L., and Logigian E.L. The overdiagnosis of Lyme disease. JAMA 269 (1993) 1812-1816
21. Klempner M.S., Schmid C.H., Hu L., et al. Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med 110 (2001) 217-219
22. Fukuda K., Nisenbaum R., Stewart G., et al. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA 280 (1998) 981-988
23. Sigal L.H., and Hassett A.L. Contributions of societal and geographical environments to "Chronic Lyme Disease": the psychopathogenesis and aporology of a new "medically unexplained symptoms" syndrome. Environ Health Perspect 110 Suppl 4 (2002) 607-611
24. Solomon S.P., Hilton E., Weinschel B.S., et al. Psychological factors in the prediction of Lyme disease course. Arthritis Care Res 11 (1998) 419-426
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), 4th edn, text revision (2000), American Psychiatric Press, Inc, Washington, DC
26. Wharton M., Chorba T.L., Vogt R.L., et al. Case definitions for public health surveillance. MMWR Recomm Rep 39 RR-13 (1990) 1-43
27. Wormser G.P., Nadelman R.B., Dattwyler R.J., et al. Guidelines from the Infectious Disease Society of America. Practice guidelines for the treatment of Lyme disease. Clin Infect Dis 31 Suppl 1 (2000) S1-S14
28. Wolfe F., Smythe H.A., Yunus M.B., et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33 (1990) 160-172
29. Spitzer R.L., Williams J.B., Kroenke K., et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 272 (1994) 1749-1756
30. Spitzer R.L., Williams J.B., Gibbon M., and First M.B. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 49 8 (1992) 624-629
31. Millon T., Davis R., and Millon C. MCMI-III Manual. 2nd edn. (1997), NCS Pearson, Inc, Minneapolis
32. Rogers R., Salekin R.T., and Sewell K.W. Validation of the Millon Clinical Multiaxial Inventory for disorders: does it meet the Daubert standard?. Law Hum Behav 23 (1999) 425-443
33. Guthrie P.C., and Mobley B.D. A comparison of the differential diagnostic efficiency of three personality disorder inventories. J Clin Psychol 50 (1994) 656-665
34. Rosenstiel A.K., and Keefe F.J. The use of coping strategies in lower back pain patients: relationships to patient characteristics and current adjustment. Pain 17 (1983) 33-40
35. Edwards R.R., Bingham III C.O., Bathon J., and Haythornthwaite J.A. Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases. Arthritis Rheum 55 (2006) 325-332
36. Swartzman L.C., Gwadry F.G., Shapiro A.P., and Teasell R.W. The factor structure of the Coping Strategies Questionnaire. Pain 57 (1994) 311-316
37. Watson D., Clark L.A., and Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Personality Soc Psychol 54 (1988) 1063-1070
38. Burckhardt C.S., Clark S.R., and Bennett R.M. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 18 (1991) 728-733
39. Fallon J., Bujak D.I., Guardino S., and Weinstein A. The Fibromyalgia Impact Questionnaire: a useful tool in evaluating patients with Post-LD Syndrome. Arthritis Care Res 12 (1999) 42-47
40. Somers R.H. A new asymmetric measure of association for ordinal variables. Am Sociol Rev 27 (1962) 799-811
41. R Development Core Team. R: A Language and Environment for Statistical Computing (2007), R Foundation for Statistical Computing, Vienna, Austria
42. Kessler R.C., Chiu W.T., Demler O., and Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV Disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62 (2005) 617-627
43. Lenzenweger M.F., Lane M.C., Loranger A.W., and Kessler R.C. DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry 62 (2007) 553-564
44. Thieme K., Turk D.C., and Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med 66 (2004) 837-844
45. Lamberg L. Personality disorder a possibility in "problem" patients, specialists say. JAMA 296 (2006) 1341-1342
46. Giesecke T., Williams D.A., Harris R.E., et al. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 50 (2004) 2716 author reply 2716-2717
47. Baker P.J. Perspectives on "Chronic Lyme Disease". Am J Med 121 (2008) 562-564
48. Moellering Jr. R.C., Graybill J.R., McGowan Jr. J.E., and Corey L. American Society for Microbiology. Antimicrobial resistance prevention initiative-an update: proceedings of an expert panel on resistance. Am J Infect Control 35 (2007) S1-S23
49. Schiff G.D., Wisniewski M., Bult J., et al. Improving inpatient antibiotic prescribing: insights from participation in a national collaborative. Jt Comm J Qual Improv 27 (2001) 387-402